CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 5 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,629,496 | +16.3% | 59,809 | +9.4% | 0.31% | +3.0% |
| Q3 2022 | $1,401,000 | +0.1% | 54,651 | -24.7% | 0.30% | +64.0% |
| Q3 2017 | $1,400,000 | +54.9% | 72,542 | -5.4% | 0.19% | +24.8% |
| Q2 2017 | $904,000 | -7.8% | 76,643 | -14.3% | 0.15% | -3.2% |
| Q1 2017 | $980,000 | -44.7% | 89,390 | -63.4% | 0.15% | -34.5% |
| Q4 2016 | $1,771,000 | +31.9% | 243,938 | +9.2% | 0.24% | +49.7% |
| Q2 2015 | $1,343,000 | +6.8% | 223,452 | -0.5% | 0.16% | +8.3% |
| Q1 2015 | $1,257,000 | – | 224,541 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |